[Federal Register: September 17, 1999 (Volume 64, Number 180)] [Notices] [Page 50515-50516] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17se99-72] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [INFO-99-39] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) and ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice. Proposed Project 1. Studies of Adverse Reproductive Outcomes in Female Occupation Groups (0920-0367)--EXTENSION--National Institute for Occupational Safety and Health (NIOSH). An estimated 50,000 to 60,000 chemicals are in common use throughout society today and hundreds of new chemicals are introduced each year. Yet the list of environmental chemicals and agents that have been investigated to determine whether they have adverse effects on reproductive health is still limited. With the growing number of women in the work force, it is becoming increasingly important to evaluate the potential female reproductive health effects of occupational and physical agents. This study will examine reproductive disorders among female flight attendants. Approximately 66,000 flight attendants are currently employed by [[Page 50516]] U.S. commercial airlines and are potentially exposed to ionizing radiation and disruption of circardin rhythms, two exposures that may adversely affect reproductive function. Teachers will be enrolled as an external comparison group for this study. Data from company personnel records containing demographic and work history information will be used to estimate workplace exposures. Each women will be asked to complete a telephone questionnaire on reproductive history and other factors (such as cigarette smoking) that may influence reproductive function. Each questionnaire will take approximately 60 minutes to complete. Medical records will be requested to confirm adverse reproductive outcomes reported by the participants. The risk of adverse reproductive outcomes between the two groups of women will then be compared. The total cost to respondents to estimated at $102,000. ---------------------------------------------------------------------------------------------------------------- Number of Respondents Number of responses Avg. burden Total burden respondents respondent per response ---------------------------------------------------------------------------------------------------------------- Workers......................................... 6,200 1 1.0 6,200 Medical providers............................... 1,200 1 0.5 600 --------------------------------------------------------------- Total....................................... .............. .............. .............. 6,800 ---------------------------------------------------------------------------------------------------------------- Dated: September 13, 1999. Nancy Cheal, Acting Associate Director for Policy, Planning and Evaluation, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-24230 Filed 9-16-99; 8:45 am] BILLING CODE 4163-18-M